Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Profound Medical (PROF)
NASDAQ:PROF
Holding PROF?
Track your performance easily
PROF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.11 - $11.42
Previous Close$7.52
Volume44.23K
Average Volume (3M)48.24K
Market Cap
$186.26M
Enterprise Value$158.84M
Total Cash (Recent Filing)$34.08M
Total Debt (Recent Filing)$6.65M
Price to Earnings (P/E)―
Beta0.71
Next Earnings
Mar 11, 2025EPS Estimate
-$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.34
Shares Outstanding24,481,835
10 Day Avg. Volume38,650
30 Day Avg. Volume48,237
Standard Deviation0.25
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)4.81
Price to Sales (P/S)24.96
Price to Cash Flow (P/CF)-7.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue20.16
Enterprise Value/Gross Profit36.25
Enterprise Value/Ebitda-6.18
Forecast
1Y Price Target
$14.50Price Target Upside92.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Profound Medical News
PremiumCompany Announcements
Profound Medical to Present at Stifel Conference
PremiumCompany Announcements
Profound Medical Sees Strong Growth with TULSA-PRO®
PremiumCompany Announcements
Profound Medical’s TULSA Gains CMS Reimbursement Boost
PremiumCompany Announcements
Profound Medical’s Q3 Results and Innovations
PremiumCompany Announcements
Profound Medical Names New Chief Commercial OfficerOptions Prices
Currently, No data available
---
Ownership Overview
18.88% Insiders
1.81% Mutual Funds
28.13% Other Institutional Investors
51.12% Public Companies and
Individual Investors
PROF FAQ
What was Profound Medical’s price range in the past 12 months?
Profound Medical lowest stock price was $7.11 and its highest was $11.42 in the past 12 months.
What is Profound Medical’s market cap?
Currently, no data Available
When is Profound Medical’s upcoming earnings report date?
Profound Medical’s upcoming earnings report date is Mar 11, 2025 which is in 107 days.
How were Profound Medical’s earnings last quarter?
Profound Medical released its earnings results on Nov 07, 2024. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of -$0.3 by -$0.08.
Is Profound Medical overvalued?
According to Wall Street analysts Profound Medical’s price is currently Undervalued.
Does Profound Medical pay dividends?
Profound Medical does not currently pay dividends.
What is Profound Medical’s EPS estimate?
Profound Medical’s EPS estimate is -$0.34.
How many shares outstanding does Profound Medical have?
Profound Medical has 24,661,772 shares outstanding.
What happened to Profound Medical’s price movement after its last earnings report?
Profound Medical reported an EPS of -$0.38 in its last earnings report, missing expectations of -$0.3. Following the earnings report the stock price went down -2.344%.
Which hedge fund is a major shareholder of Profound Medical?
Currently, no hedge funds are holding shares in PROF
---
Profound Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.50 (92.01% Upside)
$14.50 (92.01% Upside)
Blogger Sentiment
Bullish
PROF Sentiment 100%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.95%
12-Months-Change
Fundamentals
Return on Equity
-90.83%
Trailing 12-Months
Asset Growth
-16.34%
Trailing 12-Months
Company Description
Profound Medical
Profound Medical Corp is a medical technology company. It provides incision-free therapies that combine real-time Magnetic Resonance (MR) imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. The company develops a treatment to ablate the prostate gland in prostate cancer patients.
---
PROF Stock 12 Month Forecast
Average Price Target
$14.50
▲(92.01% Upside)
Technical Analysis
HLS Therapeutics Inc
―
MedX Health
―
Reliq Health Technologies
―
Medmira
―
Profound Medical
―
Best Analysts Covering PROF
1 Year
1 Year Success Rate
4/12 ratings generated profit
1 Year Average Return
-0.96%
reiterated a buy rating 16 days ago
Copying Ben Haynor's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -0.96% per trade.
---